Bill Meagher's focus with The Deal is on small and microcap equity finance, healthcare and biotechnology, PIPEs, and companies going public. His work has appeared in newspapers and magazines throughout California as well as on PBS, “60 Minutes,” ABC News and CNBC. Meagher has also written video scripts and produced national events for a non-profit educational organization and ghost written two books.
Recent Articles By The Author
White House May Be Close to Unveiling New Measures to Combat Opioid Crisis
Though the Trump administration has slow-walked help on opioids, new measures may debut next week.
Canopy Growth Likely Merger Partner For Alcaliber
Canopy Growth, maybe the biggest name in the Canadian cannabis sector, may have the inside track to scoop up Alcaliber SA, a Spanish company which produces more Morphine than anyone in the world.
Generic Drug Sector Shifting With Legal Pressure, Changes at FDA
A massive price-fixing lawsuit brought by 45 states against a group of generic drug producers as well as a changing of the guard at the Food and Drug Administration may lead to changes in the generic drug sector.
Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
Affinor Growers Sells $3.1 Million in Common Stock Behind Positive Weed Yields
In the latest weed news, Affinor Growers just sold a bunch of stock. This is what we know.